Regeneron Pharmaceuticals Stock Forecast

Stock Price Forecast

The 24 analysts with 12-month price forecasts for REGN stock have an average target of 973.17, with a low estimate of 720 and a high estimate of 1,189. The average target predicts an increase of 8.86% from the current stock price of 893.99.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$720	$973.17	$980	$1,189
Change	-19.46%	+8.86%	+9.62%	+33.00%

Analyst Ratings

The average analyst rating for REGN stock from 24 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '23	Dec '23	Jan '24	Feb '24	Mar '24	Apr '24
Strong Buy	7	7	7	7	7	7
Buy	11	11	12	12	13	11
Hold	4	4	4	4	4	5
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	23	23	24	24	25	24

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Colin Bristow UBS	UBS	Strong Buy Maintains $1,090 → $1,099	Strong Buy	Maintains	$1,090 → $1,099	+22.93%	Apr 17, 2024
Olivia Brayer Cantor Fitzgerald	Cantor Fitzgerald	Hold Reiterates $925	Hold	Reiterates	$925	+3.47%	Apr 17, 2024
Louise Chen Cantor Fitzgerald	Cantor Fitzgerald	Hold Reiterates $925	Hold	Reiterates	$925	+3.47%	Apr 15, 2024
Geoff Meacham B of A Securities	B of A Securities	Sell Maintains $710 → $720	Sell	Maintains	$710 → $720	-19.46%	Apr 12, 2024
Brian Abrahams RBC Capital	RBC Capital	Buy Reiterates $1,189	Buy	Reiterates	$1,189	+33.00%	Apr 9, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

14.21B

from 13.12B

8.29%

from 13.12B

Revenue Next Year

15.27B

from 14.21B

7.50%

from 14.21B

EPS This Year

45.76

from 34.77

31.59%

from 34.77

EPS Next Year

48.30

from 45.76

5.57%

from 45.76

Year	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028
Revenue	6.56B	8.50B	16.07B	12.17B	13.12B	14.21B	15.27B	16.27B	16.34B	17.22B
Revenue Growth	27.44%	29.58%	89.14%	-24.26%	7.76%	8.29%	7.50%	6.52%	0.47%	5.36%
EPS	18.46	30.52	71.97	38.22	34.77	45.76	48.30	52.72	55.51	59.65
EPS Growth	-13.29%	65.33%	135.81%	-46.89%	-9.03%	31.59%	5.57%	9.15%	5.29%	7.44%
No. Analysts	-	-	-	-	-	30	29	23	14	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	15.5B	18.0B	18.6B	20.3B	20.9B
Avg	14.2B	15.3B	16.3B	16.3B	17.2B
Low	12.8B	13.6B	13.3B	12.3B	12.3B

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	18.1%	27.0%	21.8%	24.5%	27.7%
Avg	8.3%	7.5%	6.5%	0.5%	5.4%
Low	-2.6%	-3.9%	-12.7%	-24.4%	-24.5%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	55.23	59.22	63.82	72.14	76.19
Avg	45.76	48.30	52.72	55.51	59.65
Low	35.75	40.90	39.71	38.95	40.22

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	58.8%	29.4%	32.1%	36.8%	37.2%
Avg	31.6%	5.6%	9.1%	5.3%	7.4%
Low	2.8%	-10.6%	-17.8%	-26.1%	-27.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.